The Neuroblate Fusion system utilizes magnetic resonance guided laser therapy to ablate tumors and lesions. The system requires the use of Laser Interstitial Thermo Therapy (LITT) to activate thermocoagulation and focus of tissue destruction. This is a minimally invasive alternative to traditional brain surgery, giving patients a shorter recovery time and fewer complications. Neuroblate Fusion may also be an additional treatment to chemotherapy or radiation therapy. Neuroblate Fusion is best used for treating glioblastomas in the brain and occasionally for reducing the potential for seizures. Under sterile conditions, a small burr hole is made in the patient’s skull which allows the neurosurgeon to accurately place the probe onto the area of interest. Concurrently with the neurological procedure, real-time magnetic resonance imaging (MRI) is performed. This helps to assist the surgeons in precisely locating the glioblastoma and destroy the carcinogenic tissues with the laser, while avoiding the surrounding healthy tissues and anatomy. Neuroblate Fusion is a great treatment option for patients who are suffering with aggressive tumors such as glioblastomas. Laser therapy gives patients a new hope and a better chance of survival. Recurrence of glioblastomas are common after patients undergo a first surgery without the use of Neuroblate Fusion. Destroying the tumor proves to be more successful after a second surgery is done using laser therapy. In the future, Neuroblate Fusion may become the gold standard for treating glioblastomas.
Magnetic Resonance, Neuroblate Fusion, Glioblastoma
Neurosurgery | Radiology
Goldy, Amanda, "Magnetic Resonance Neuroblate Fusion for Treating Glioblastomas" (2021). Student Research Poster Presentations 2021. 77.